Beijing LabTech Instruments Co., Ltd (Stock Code: 688056) is a high-tech enterprise specializing in the research and development, production and sales of experimental analytical instruments, providing clean and environment-friendly laboratory solutions, laboratory consumables and related services, and it belongs to the high-end manufacturing industry encouraged and supported by the state.Since its establishment, the company has always been committed to the research and development of automatic experimental testing platform, which connects the whole testing process including sample collection and processing, automatic sampling, analysis and testing, intelligent data analysis, and covers and connects all links of experimental analysis. For environmental monitoring (water, air, soil testing), food testing, medical and health, geological survey and other fields of users to provide automatic, systematic experimental analysis and detection of the overall solution. The company is one of the world's leading suppliers of laboratory analytical instruments that can combine multi-type and multi-function sample pretreatment technology and automatic analytical laboratory analysis and testing platform into automatic analytical instrument system.
In recent years, the company adheres to the national industrial policy guidance, focusing on food testing, environmental monitoring (water, air, soil testing), agricultural products testing, commodity testing and other fields of experimental analysis instrument research and development production system. It covers many critical areas of national development and related to people's livelihood, such as drug quality testing, new drug development, new material research, nuclide separation, medical diagnosis, disease control and life science.
The company's products have advanced technology and reliable performance characteristics, and users have been widely praised and supported. The company's automatic solid phase extraction products have won the BCEIA gold award, a number of products have won the "China good instrument" award, the company has been rated as the "most influential domestic manufacturer in the scientific instrument industry" for many consecutive years.
The company haswell-known brands such as LabTech, CDS, Empore and other industry famous brands, and has R&D and production bases in China and the United States, as well as product marketing and service centers in major cities in mainland China, Hong Kong, Massachusetts and Pennsylvania in USA. In recent years, the company established the experimental analysis instrument research and development innovation system, accumulated strong technical strength and research and development achievements, the core technical staff in the domestic and foreign related journals and magazines published many SCI articles. Up to now, The company's products have been sold to more than 90 countries and regions around the world, serving more than 30,000 customers in total.
| Full name | Beijing LabTech Instruments Co., Ltd. |
|---|---|
| Abbreviations | LabTech |
| Code | 688056 |
| Founded | 2002-01-08 |
| Listing | 2020-09-02 |
| Domicile | Beijing |
| Website | www.labtechgroup.com |
| zqtzb@labtechgroup.com | |
| STAR Theme | High-end Equipment |
| CSRC Sector | Manufacturing |
| Has weighted voting rights structure? | No |
| 2020 | 2019 | 2018 | |
|---|---|---|---|
| Earnings Per Share | 1.17 | 1.23 | 1.20 |
| R&D expenditure as a % of operating revenue | 8.42% | 6.79% | 3.82% |
| Operating Revenue | 348.60 | 380.52 | 350.06 |
| Net Income | 65.30 | 61.68 | 59.94 |
| 2020 | 2019 | 2018 | |
|---|---|---|---|
| Operating Revenue | 348.60 | 380.52 | 350.06 |
| Operating Costs | 278.56 | 307.26 | 279.61 |
| Operating Income | 69.23 | 73.51 | 63.97 |
| Pretax Income | 76.41 | 73.66 | 69.93 |
| Income Tax | 11.12 | 11.98 | 9.99 |
| Net Income | 65.30 | 61.68 | 59.94 |
| 2020 | 2019 | 2018 | |
|---|---|---|---|
| Assets | |||
| Current Assets-Total | 757.16 | 351.07 | 346.63 |
| Non-current Assets-Total | 95.21 | 98.55 | 80.16 |
| Total Assets | 852.37 | 449.62 | 426.79 |
| Liabilities | |||
| Current Liabilities-Total | 107.04 | 119.60 | 121.51 |
| Non-current Liabilities-Total | 4.41 | 2.51 | 8.90 |
| Total Liabilities | 111.45 | 122.11 | 130.41 |
| Stockholder's Equity | |||
| Share Capital | 463.97 | 89.48 | 92.12 |
| Retained Profits | 276.08 | 237.25 | 203.50 |
| Minority Interests | 0.87 | 0.78 | 0.76 |
| Total Owners' Equity | 740.92 | 327.51 | 296.38 |
| 2020 | 2019 | 2018 | |
|---|---|---|---|
| Net Cash Flows-Operating | 83.54 | 51.55 | 43.92 |
| Net Cash Flows-Investing | -167.48 | -27.50 | -0.93 |
| Net Cash Flows-Financing | 345.85 | -22.32 | 0.00 |
| Name | No. of Shares Held (mn) | % of Shares Held |
|---|---|---|
| Beijing LabTech Management Consulting Co., Ltd. | 24.18 | 36.09% |
| LabTech Holdings,Inc. | 16.12 | 24.06% |
| Beijing HongJingHaoRun Management Consulting Co., Ltd. | 5.50 | 8.21% |
| WI Harper Fund VII Hong Kong Limited | 3.71 | 5.53% |
| 中国工商银行股份有限公司－中欧价值智选回报混合型证券投资基金 | 1.24 | 1.85% |
| 广发证券股份有限公司－中庚小盘价值股票型证券投资基金 | 1.22 | 1.82% |
| China Merchants Securities Investment co., ltd | 0.57 | 0.85% |
| Beijing JingYeChengCheng Consulting Co., Ltd. | 0.50 | 0.75% |
| 招商银行股份有限公司－鹏华弘嘉灵活配置混合型证券投资基金 | 0.44 | 0.65% |
| 招商银行股份有限公司－泰康品质生活混合型证券投资基金 | 0.41 | 0.61% |
All information contained herein is provided by the underlying company itself and is for informational purposes only, and nothing contained herein should be construed as investment advice, either on behalf of a particular security or an overall investment strategy. The Shanghai Stock Exchange does not guarantee its accuracy and reliability and shall under no circumstance be responsible or liable for any error or for any loss directly or indirectly arising from any inaccuracy or omission or from any decision, action or non-action based on or in reliance upon the information herein.
Users may view and download the information herein for personal and non-commercial use free of charge subject to the laws of the People's Republic of China and the Legal Statement. No part of the information herein may be copied, downloaded, stored in a retrieval system or transmitted in any form or by any means, rented, displayed, performed, reproduced, photocopied, altered, sold, broadcast, published or otherwise in whole or in part in any manner for commercial purposes, without the prior written consent of the Shanghai Stock Exchange.
Users are hereby reminded that the Legal Statement represents your legally binding agreement with the Shanghai Stock Exchange. By accessing or using this website, you are also signifying your agreement with and acceptance of all the contents in the Legal Statement. The Shanghai Stock Exchange reserves the right to amend and interpret the Legal Statement.